Abstract:High penetrance genes such as BRCA1 or BRCA2 account for only a small proportion of familial breast cancer in Chinese population. Estrogen has been proposed to participate in the proliferation and carcinogenesis of breast cancer. To investigate the association between genetic polymorphisms in genes encoding estrogen metabolizing, estrogen biosynthesizing enzyme and estrogen receptor and the breast cancer risk in BRCA1/BRCA2 negative Shanghai women, we conducted a case-control study including 114 cases with early-onset breast cancer or affected relatives and 121 healthy controls. The genotypes of estrogen receptor alpha (ER alpha), aromatase (CYP19), and catechol-O-methyltransferase (COMT) genes were analyzed by direct DNA-sequencing. Compared with H/H genotype of COMT Val158Met, COMT Val158Met L/L genotype was associated with a nonsignificantly elevated risk of breast cancer (OR: 3.72; 95% CI: 0.99-13.96, P = 0.051). There was no statistically significant difference in genotype frequency of the ER alpha PvuII, ER alpha XbaI and CYP19 Arg264Cys polymorphism between controls and cases. When stratified by menopausal status, COMT Val158Met L/L (OR: 11.94; 95% CI: 1.48-96.03, P = 0.02) and ER alpha PvuII P/p genotypes (OR: 2.67; 95% CI: 1.01-7.05, P = 0.048) were associated with a significantly elevated risk of breast cancer in premenopausal women, and there was a association between ER alpha XbaI x/x genotype and the nonsignificantly increased risk of breast cancer in premenopausal women (OR: 6.88; 95% CI: 0.80-59.15, P = 0.079). The multigenic analysis showed maybe these high risk genotypes had combined effect on breast cancer risk. Our findings suggest that polymorphism of genes involving estrogen-metabolizing pathway, estrogen- biosynthesizing pathway and estrogen receptor pathway may play an important role in the etiology of BRCA1/2 negative breast cancer with hereditary predisposing factors.

Correlation of Polymorphism in Estrogen Metabolizing Genes CYP17 and Estrogen Exposure and Its Relation with Breast Cancer Susceptibility

[Association of XPC gene polymorphisms with breast cancer risk].

[A Case-Control Study on the Association Between Genetic Polymorphisms of Metabolic Enzymes and the Risk of Colorectal Cancer].

[Association Between Genetic Polymorphisms of Metabolic Enzymes and Susceptibility of Colorectal Cancer].

Association of p53 polymorphisms and its haplotypes with susceptibility of breast cancer]

Association of CYP2C19*3 Gene Polymorphism with Breast Cancer in Chinese Women.

Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women

CYP17 Polymorphisms Are Associated with Decreased Risk of Breast Cancer in Chinese Han Women: a Case-Control Study

Genetic Polymorphisms in the Estrogen Receptor Α Gene and Risk of Breast Cancer

A Multigenic Study on Breast Cancer Risk Associated with Genetic Polymorphisms of ER Alpha , COMT and CYP19 Gene in BRCA1/BRCA2 Negative Shanghai Women with Early Onset Breast Cancer or Affected Relatives

Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.

Genetic Polymorphisms in Estrogen-Metabolizing Genes and Breast Cancer Survival

Polymorphisms in the CYP19A1 (Aromatase) Gene and Endometrial Cancer Risk in Chinese Women

Genetic Polymorphisms of Estrogen Receptor Genes Are Associated with Breast Cancer Susceptibility in Chinese Women

Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined.

Polymorphisms inCYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women

Nucleotide Excision Repair Pathway Gene Polymorphisms Are Linked to Breast Cancer Risk in a Chinese Population

The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population

Correlation between Polymorphisms of CYP3A5 and CYP2D6 Genotypes with Concentrations of Tamoxifen and its Activity Metabolism 4-Hydroxytamoxifen in Chinese Breast Cancer Patients

Association Between ESR1 Gene Polymorphisms and Breast Cancer Risk

Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk.